# The Influence of Acute Beta-Hydroxy Beta-Methylbutyrate (HMB) Ingestion on the Human Skeletal Muscle Transcriptome

**Authors:** Daniel J. Wilkinson, Iain J. Gallagher, Hannah Crossland, Suzette L. Pereira, Ricardo Rueda, Bethan E. Phillips, Kenneth Smith, Colleen S. Deane, Philip J. Atherton

PMC · DOI: 10.3390/nu18030434 · Nutrients · 2026-01-28

## TL;DR

This study shows that HMB, a metabolite of leucine, changes gene activity in muscle, supporting muscle protein balance and function.

## Contribution

The study is the first to examine HMB's effects on the muscle transcriptome, revealing novel gene pathways involved in muscle proteostasis.

## Key findings

- HMB significantly upregulated 468 genes and downregulated 326 genes in skeletal muscle.
- Key pathways affected include JAK-STAT signaling, circadian rhythm, TNFα signaling, and protein synthesis.
- HMB increased expression of amino acid transporters SLC36A1 and SLC7A5.

## Abstract

Background: Nutritional interventions to mitigate age/disease-related skeletal muscle attrition are much needed given the growing older population. Beta-hydroxy beta-methylbutyrate (HMB), an endogenous metabolite of the essential amino acid leucine, has anabolic properties in skeletal muscle: acutely stimulating muscle protein synthesis and attenuating muscle protein breakdown. While the role of supplemental HMB on muscle protein turnover is established, mechanistic effects on the muscle transcriptome have not been examined. Methods: Total RNA was extracted from m. vastus lateralis muscle biopsies of young males (n = 14) before and ~2.5 h after oral consumption of ~3 g HMB. Global changes in the muscle transcriptome were assessed via RNA sequencing, and differential expression in genes between fasted and ‘fed’ (HMB) conditions was determined. To identify the functional biology of differentially expressed genes, gene set enrichment and active subnetwork-orientated enrichment analyses was performed. Results: Of 15,982 genes detected, 468 were significantly upregulated and 326 were significantly downregulated in response to HMB. These genes were found to be associated with molecular pathways regulating muscle protein turnover, most notably, JAK-STAT signalling (e.g., STAM), circadian rhythm (e.g., NR1D1, NR1D2, PER2, PER3), TNFα signalling (e.g., TNFRSF1A, CCL2, CXCL2), and protein synthesis (e.g., POLR1A, POLR2A, POLR3A, PIK3RR, SGK1). HMB also regulated the expression of AA transporters, evoking a robust increase in SLC36A1 (PAT1) and SLC7A5 (LAT1). Conclusions: HMB evokes transcriptional events important in the homeostasis of muscle, supporting a role in proteostasis and one akin to protein intake, i.e., upregulation of AA transporters. Future work should further define HMB’s transcriptomic/proteomic effects in ageing/disease and synergy with exercise.

## Linked entities

- **Genes:** STAM (signal transducing adaptor molecule) [NCBI Gene 8027], NR1D1 (nuclear receptor subfamily 1 group D member 1) [NCBI Gene 9572], NR1D2 (nuclear receptor subfamily 1 group D member 2) [NCBI Gene 9975], PER2 (period circadian regulator 2) [NCBI Gene 8864], PER3 (period circadian regulator 3) [NCBI Gene 8863], TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132], CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347], CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920], POLR1A (RNA polymerase I subunit A) [NCBI Gene 25885], POLR2A (RNA polymerase II subunit A) [NCBI Gene 5430], POLR3A (RNA polymerase III subunit A) [NCBI Gene 11128], SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446], SLC36A1 (solute carrier family 36 member 1) [NCBI Gene 206358], SLC7A5 (solute carrier family 7 member 5) [NCBI Gene 8140]
- **Chemicals:** Beta-hydroxy beta-methylbutyrate (PubChem CID 69362), leucine (PubChem CID 857)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, NR1D2 (nuclear receptor subfamily 1 group D member 2) [NCBI Gene 9975] {aka BD73, EAR-1R, REVERBB, REVERBbeta, RVR}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, SLC7A5 (solute carrier family 7 member 5) [NCBI Gene 8140] {aka 4F2LC, CD98, D16S469E, E16, LAT1, MPE16}, POLR3A (RNA polymerase III subunit A) [NCBI Gene 11128] {aka ADDH, C160, HLD7, RPC1, RPC155, WDRTS}, PER2 (period circadian regulator 2) [NCBI Gene 8864] {aka FASPS, FASPS1}, SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446] {aka SGK}, TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132] {aka CD120a, FPF, TBP1, TNF-R, TNF-R-I, TNF-R55}, STAM (signal transducing adaptor molecule) [NCBI Gene 8027] {aka STAM-1, STAM1}, CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920] {aka CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2}, SLC36A1 (solute carrier family 36 member 1) [NCBI Gene 206358] {aka Dct1, LYAAT1, PAT1, TRAMD3}, POLR2A (RNA polymerase II subunit A) [NCBI Gene 5430] {aka NEDHIB, POLR2, POLRA, RPB1, RPBh1, RPO2}, NR1D1 (nuclear receptor subfamily 1 group D member 1) [NCBI Gene 9572] {aka EAR1, REVERBA, REVERBalpha, THRA1, THRAL, ear-1}, PER3 (period circadian regulator 3) [NCBI Gene 8863] {aka FASPS3, GIG13}, POLR1A (RNA polymerase I subunit A) [NCBI Gene 25885] {aka A190, AFDCIN, HLD27, RPA1, RPA190, RPA194}
- **Chemicals:** Beta-Hydroxy Beta-Methylbutyrate (MESH:C004961), essential amino acid (MESH:D000601), leucine (MESH:D007930)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12899265/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12899265/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12899265/full.md

---
Source: https://tomesphere.com/paper/PMC12899265